The Association among Antioxidant Enzymes, Autoantibodies, and Disease Severity Score in Systemic Lupus Erythematosus: Comparison of Neuropsychiatric and Nonneuropsychiatric Groups

Table 2

Clinical data of SLE patients.

	SLE		Total, n = 32
	NPSLE, n = 15	Non-NPSLE, n = 17
Clinical symptoms
Constitutional	0	2	2
Vasculitis	2	2	4
Mucocutaneous involvement	2	3	5
Neurological involvement	15	0	15
Musculoskeletal involvement	2	10	12
Cardiorespiratory involvement	2	0	2
Renal involvement	2	8	10
Hematologic involvement	2	2	4
Median (IQR) SLEDAI-2K	8 (6.00, 14.00)	5.5 (2.25, 11.75)	6 (4.00, 12.00)
Mean dosage of medication
Prednisolone	21.59 (mg/day) (n = 11)	18.90 (mg/day) (n = 5)	20.76 (mg/day) (n = 16)
Hydroxychloroquine	360 (mg/day) (n = 10)	250 (mg/day) (n = 12)	300 (mg/day) (n = 22)
Azathioprine	50 (mg/day) (n = 2)	50 (mg/day) (n = 1)	50 (mg/day) (n = 3)
Mycophenolate	1080 (mg/day) (n = 1)	0	1080 (mg/day) (n = 1)
Cyclophosphamide	500 (mg/month) (n = 1)	0	500 (mg/month) (n = 1)
Cyclosporine	25 (mg/day) (n = 1)	50 (mg/day) (n = 3)	43.75 (mg/day) (n = 4)